Relationship of the 1793G-A and 677C-T polymorphisms of the 5,10-methylenetetrahydrofolate reductase gene to coronary artery disease

Disease Markers

Volumn 22, Issue 5-6, 2006, Pages 293-301

  Kebert, Cory B ^a   Eichner, June E ^b   Moore, William E ^b   Schechter, Eliot ^a   Yaoi, Takuro ^c   Vogel, Steve ^a   Allen, Richard A ^a   Dunn, S Terence ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c FreshGene Inc   (United States)

Author keywords

Atherosclerosis; C677T; CAD; G1793A; Holliday junction; Homocysteine; Methylenetetrahydrofolate reductase; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; AFRICAN AMERICAN; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENZYME POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOLLIDAY JUNCTION; HOMOZYGOTE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTANT; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 33847346938     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/825431     Document Type: Article

References (46)

1. K.K. Abu-Amero, C.A. Wyngaard and N. Dzimiri, Prevalence and role of methylenetetrahydrofolate reductase 677 C→T and 1298 A→C polymorphisms in coronary artery disease in Arabs, Archives of Pathology & Laboratory Medicine 127 (2003), 1349-1352.
2. C.J. Boushey, S.A. Beresford, G.S. Omenn and A.G. Motulsky, A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes, Journal of the American Medical Association 274 (1995), 1049-1057.
3. L. Brattstrom and D.E. Wilcken, Homocysteine and cardiovascular disease: cause or effect? The American Journal of Clinical Nutrition 72 (2000), 315-323.
4. E.S. Brilakis, P.B. Berger, K.V. Ballman and R. Rozen, Methylenetetrahydrofolate reductase (MTHFR) 677C>T and methionine synthase reductase (MTRR) 66A>G polymorphisms: association with serum homocysteine and angiographic coronary artery disease in the era of flour products fortified with folic acid, Atherosclerosis 168 (2003), 315-322.
5. B. Christensen, L. Arbour, P. Tran, D. Leclerc, N. Sabbaghian, R. Platt, B.M. Gilfix, D.S. Rosenblatt, R.A. Gravel, P. Forbes and R. Rozen, Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects, American Journal of Human Genetics 84 (1999), 151-157.
6. A. Dilley, W.C. Hooper, M. El-Jamil, M. Renshaw, N.K. Wenger and B.L. Evatt, Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C→T677) and cystathione beta-synthase (CBS G→A919, CBS T→C833) are not associated with myocardial infarction in African Americans, Thrombosis Research 103 (2001), 109-115.
7. J.E. Eichner, V.J. Christiansen, W.E. Moore, S.T. Dunn and E. Schechter, Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients, Atherosclerosis 154 (2001), 673-679.
8. O. Fletcher and A.M. Kessling, MTHFR association with arteriosclerotic vascular disease? Human Genetics 103 (1998), 11-21.
9. P. Frosst, H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, R.G. Matthews, G.J.H. Boers, M. den Heijer, L.A.J. Kluijtmans, L.P. van den Heuvel and R. Rozen, A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, Nature Genetics 10 (1995), 111-113.
10. D. Gemmati, M.L. Serino, C. Trivellato, S. Fiorini and G.L. Scapoli, C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients, Haematologica 84 (1999), 824-828.
11. D. Girelli, N. Martinelli, F. Pizzolo, S. Friso, O. Olivieri, C. Stranieri, E. Trabetti, G. Faccini, E. Tinazzi, P.F. Pignatti and R. Corrocher, The interaction between MTHFR 677 C→T genotype and folate status is a determinant of coronary atherosclerosis risk, The Journal of Nutrition 133 (2003), 1281-1285.
12. G. Hasegawa, H. Obayashi, K. Kamiuchi, M. Nakai, T. Kanatsuna, M. Yamaguchi, T. Tanaka, H. Shigeta, M. Fujii, T. Yoshikawa and N. Nakamura, The association between endstage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitus, Experimental and Clinical Endocrinology & Diabetes 111 (2003), 132-138.
13. H.J. Huh, H.S. Chi, E.H. Shim, S. Jang and C.J. Park, Genenutrition interactions in coronary artery disease: Correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population, Thrombosis Research (2005), Epub ahead of print.
14. P.A. Isotalo, G.A.Wells and J.G. Donnelly, Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations, American Journal of Human Genetics 67 (2000), 986-990.
15. S.-S. Kang, J. Zhou, P.W.K. Wong, J. Kowalisyn and G. Strokosch, Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase, American Journal of Human Genetics 43 (1988), 414-421.
16. S.-S. Kang, P.W.K. Wong, A. Susmano, J. Sora, M. Norusis and N. Ruggie, Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease, American Journal of Human Genetics 48 (1991), 536-545.
17. P.J.Kelly, J. Rosand, J.P. Kistler, V.E. Shih, S. Silveira, A. Plomaritoglou and K.L. Furie, Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke: results of a metaanalysis, Neurology 59 (2002), 529-536.
18. C.H. Kim, K.Y. Hwang, T.M. Choi, W.Y. Shin and S.Y. Hong, The methylenetetrahydrofolate reductase gene polymorphism in Koreans with coronary artery disease, International Journal of Cardiology 78 (2001), 13-17.
19. M. Klerk, P. Verhoef, R. Clarke, H.J. Blom, F.J. Kok and E.G. Schouten, MTHFR Studies Collaboration Group. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis, Journal of the American Medical Association 288 (2002), 2023-2031.
20. L.A. Kluijtmans, J.J. Kastelein, J. Lindemans, G.H. Boers, S.G. Heil, A.V. Bruschke, J.W. Jukema, L.P. van den Heuvel, F.J. Trijbels, G.J. Boerma, F.W. Verheugt, F.Willems and H.J. Blom, Thermolabile methylenetetrahydrofolate reductase in coronary artery disease, Circulation 96 (1997), 2573-2577.
21. L.A. Kluijtmans, L.P. van den Heuvel, G.H. Boers, P. Frosst, E.M. Stevens, B.A. van Oost, M. den Heijer, F.J. Trijbels, R. Rozen and H.J. Blom, Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease, American Journal of Human Genetics 58 (1996), 35-41.
22. L. Le Marchand, L.R. Wilkens, L.N. Kolonel and B.E. Henderson, The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study, Cancer Epidemiology, Biomarkers, & Prevention 14 (2005), 1198-1203.
23. J. Ma, M.J. Stampfer, E. Giovannucci, C. Artigas, D.J. Hunter, C. Fuchs, W.C. Willet, J. Selhub, C.H. Hennekens and R. Rozen, Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer, Cancer Research 57 (1997), 1098-1102.
24. A. Mager, S. Lalezari, T. Shohat, Y. Birnbaum, Y. Adler, N. Magal and M. Shohat, Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease, Circulation 100 (1999), 2406-2410.
25. H. Morita, J. Taguchi, H. Kurihara, M. Kitaoka, H. Kaneda, Y. Kurihara, K. Maemura, T. Shindo, T. Minamino, M. Ohno, K. Yamaoki, K. Ogasawara, T. Aizawa, S. Suzuki and Y. Yazaki, Genetic polymorphism of 5,10- methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease, Circulation 95 (1997), 2032-2036.
26. A.G. Motulsky, Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid, American Journal of Human Genetics 58 (1996), 17-20.
27. K. Nakai, C. Itoh, K. Nakai, W. Habano and D. Gurwitz, Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD, American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions 1 (2001), 353-361.
28. O. Nygard, S.E. Vollset, H. Refsum, L. Brattstrom and P.M. Ueland, Total homocysteine and cardiovascular disease, Journal of Internal Medicine 246 (1999), 425-454.
29. D.A. Payne, A.J. Chamoun, S.I. Seifert and G.A. Stouffer, MTHFR 677C→T mutation: a predictor of early-onset coronary artery disease, Thrombosis Research 103 (2001), 275-279.
30. P.L. Rady, S. Szucs, J. Grady, S.D. Hudnall, L.H. Kellner, H. Nitowsky, S.K. Tyring and R.K. Matalon, Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A, American Journal of Human Genetics 107 (2002), 162-168.
31. Q. Shi, Z. Zhang, G. Li, P.C. Pillow, L.M. Hernandez, M.R. Spitz and Q. Wei, Sex differences in risk of lung cancer associated with methylene- tetrahydrofolate reductase polymorphisms, Cancer Epidemiology, Biomarkers & Prevention 14 (2005), 1477-1484.
32. M.J. Shrubsole, X.O. Shu, Z.X. Ruan, Q. Cai, H. Cai, Q. Niu, Y.T. Gao and W. Zheng, MTHFR genotypes and breast cancer survival after surgery and chemotherapy: a report from the Shanghai Breast Cancer Study, Breast Cancer Research and Treatment 91 (2005), 73-79.
33. M.J. Shrubsole, Y.T. Gao, Q. Cai, X.O. Shu, Q. Dai, J.R. Hebert, F. Jin and W. Zheng, MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study, Cancer Epidemiology, Biomarkers & Prevention 13 (2004), 190-196.
34. R.E. Stevenson, C.E. Schwartz, Y.Z. Du and M.J. Adams Jr, Differences in methylenetetrahydrofolate reductase genotype frequencies, between Whites and Blacks, American Journal of Human Genetics 60 (1997), 229-230.
35. J. Sun, Y. Xu, Y. Zhu and H. Lu, Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients, Diabetes Research and Clinical Practice 64 (2004), 185-190.
36. A. Szczeklik, M. Sanak, M. Jankowski, J. Dropinski, R. Czachor, J. Musial, I. Axenti, M. Twardowska, T. Brzostek and M. Tendera, Mutation A1298C of methylenetetrahydrofolate reductase: risk for early coronary disease not associated with hyperhomocysteinemia, American Journal of Human Genetics 101 (2001), 36-39.
37. F.M. van Bockxmeer, C.D. Mamotte, S.D. Vasikaran and R.R. Taylor, Methylenetetrahydrofolate reductase gene and coronary artery disease, Circulation 95 (1997), 21-23.
38. N.M. van der Put, F. Gabreels, E.M. Stevens, J.A. Smeitink, F.J. Trijbels, T.K. Eskes, L.P. van den Heuvel and H.J. Blom, A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? American Journal of Human Genetics 62 (1998), 1044-1051.
39. N.M.J. van der Put, T.K.A.B. Eskes and H.J. Blom, Is the common 677C→T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis, The Quarterly Journal of Medicine 90 (1997), 111-115.
40. S. Voutilainen, T.H. Rissanen, J. Virtanen, T.A. Lakka and J.T. Salonen, Kuopio Ischemic Heart Disease Risk Factor Study. Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study, Circulation 103 (2001), 2674-2680.
41. I. Weisberg, P. Tan, B. Christensen, S. Sibani and R. Rozen, A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decrease enzyme activity, Molecular Genetics and Metabolism 64 (1998), 169-172.
42. I.S. Weisberg, P.F. Jacques, J. Selhub, A.G. Bostom, Z. Chen, R. Curtis Ellison, J.H. Eckfeldt and R. Rozen, The 1298A→C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine, Atherosclerosis 156 (2001), 409-415.
43. W.C. Winkelmayer, A. Huber, O.F. Wagner, W.H. Horl, G. Sunder-Plassmann and M. Fodinger, Associations between MTHFR1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients, Kidney International 67 (2005), 1980-1985.
44. W.C. Winkelmayer, G. Sunder-Plassmann, A. Huber and M. Fodinger, Patterns of co-occurrence of three single nucleotide polymorphisms of the 5,10-methylenetetrahydrofolate reductase gene in kidney transplant recipients, European Journal of Clinical Investigation 34 (2004), 613-618.
45. Q. Yang, A. Lishanski, W. Yang, S. Hatcher, H. Seet and J. Gregg, Allele-specific Holliday junction formation - a new mechanism of allelic discrimination for SNP scoring, Genome Research 13 (2003), 1754-1764.
46. H. Yilmaz, S. Isbir, B. Agachan, A. Ergen, B. Farsak and T. Isbir, C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease, Cell Biochemistry and Function (2005), Epub ahead of print.